Skip to content

Impact of Reducing the Dialysate Flow Rate in Chronic Hemodialysis on Dialysis Quality and Environmental Impact on Water Consumption

Non-inferiority Study on the Efficacy of Hemodialysis With Dialysate Flow Rates of 400 mL/Min Versus 500 mL/Min in a Population of Patients Undergoing Chronic Hemodialysis. Impact of Reducing the Dialysate Flow Rate in Chronic Hemodialysis on Dialysis Quality and Environmental Impact on Water Consumption

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07718568
Acronym
ReDeDia
Enrollment
250
Registered
2026-07-22
Start date
2027-01-01
Completion date
2029-10-01
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Disease, Chronic

Keywords

Efficicency or Quality of Hemodialysis, Green Dialysis

Brief summary

In France, 60,000 patients are receiving renal replacement therapy via dialysis in 2022, 90% of whom are on hemodialysis. This technique is based on the principle of exchange across a membrane between the patient's blood and the dialysate. The goal is to purify the patient's blood as effectively as possible by removing all solutes that have accumulated due to kidney failure. The dialysate is produced from municipal water, which is treated through several processes (reverse osmosis, filtration) to produce ultrapure water. Water consumption at the La Conception Hospital center in Marseille, which conducts 37,000 sessions per year (64 hemodialysis stations), is estimated at 120 m³ of water per day, which is discharged into the sewer system after use. In France, this would correspond to an estimated total consumption of nearly one million m³ of drinking water per year. In the context of climate change, which will lead to a reduction in water resources, it is important to rethink all aspects of water consumption. The investigator's reflection is part of a growing awareness of the environmental impact of dialysis within a working group of the Francophone Society of Nephrology, Dialysis, and Transplantation: "Green Dialysis." The quality of clearance depends on blood flow and dialysate flow rate (Qd). The Qd was set at 500 mL/min based on earlier studies that showed this flow rate corresponded to maximum clearance of urea and the main toxic solutes. These studies were conducted at a time when dialysis membranes were less efficient. Today, the investigators use membranes with higher exchange efficiency. Despite this, the investigators have not reevaluated the appropriateness of a Qd of 500 mL/min. The quality criterion in dialysis is a balanced urea Kt/V measurement \>1.2 for a 4-hour session (target set at 1.4 with certain "single-pool" dialysis machine measurement techniques). At the ivnestigator's center, the average urea Kt/V is 1.55 in "single-pool" mode. Reducing the Qd could be done without risk to patients, even if it leads to a decrease in urea Kt/V. A Colombian study with 5 years of follow-up demonstrates patient safety with a Qd of 400 mL/min (vs. 500 mL/min), with no difference in mortality or dialysis efficacy. The study population was not representative of chronic dialysis patients; 10% regained renal function, and the final analysis included only 25 of the 71 patients enrolled.

Interventions

OTHERDialysate flow at 400mL/min

Dialysate flow fixed at 400mL/min for one month.

OTHERDialysate flow at 500mL/min

Dialysate flow fixed at 500mL/min for one month.

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER
Aix Marseille Université
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * No decompensated psychiatric disorder, acute or decompensated somatic condition * Patients on hemodialysis for more than 3 months * Dialysis schedule: 3 times per week for 4 hours each session * Stable vascular access (arteriovenous fistula or tunneled central catheter) * Blood flow \> 300 mL/min * Anuric (urine output \< 500 mL/24 h) * Dialysis method: hemodialysis or hemodiafiltration

Exclusion criteria

* Age \< 18 years * Patient on dialysis for \< 3 months * Unstable vascular access * Blood flow rate \< 300 mL/min * Urine output \> 500 mL/day * Dialysis technique: hemofiltration * Severe intercurrent condition (somatic or psychiatric) * Pregnant or breastfeeding patients. * Patients who are legally incapacitated, under guardianship, or under conservatorship

Design outcomes

Primary

MeasureTime frameDescription
Mesure of Urea Kt/VDay 0, Month 1Mesure of Urea clearance by two blood samples, after dialysis minus before dialyse (of urea blood sample), at Day 0 and Month 1

Secondary

MeasureTime frameDescription
Mesure of Beta2-microglobulin clearanceDay 0, Month 1Mesure of Beta2-microglobulin clearance by two blood samples, after dialysis minus before dialyse (of urea blood sample), at Day 0 and Month 1
Potassium rate before dialysisDay 0, Month 1Mesure of Potassium rate before dialysis (Blood sample), at Day 0 and Month 1
Phosphorus rate before dialysisDay 0, Month 1Mesure of Phosphorus rate before dialysis (Blood sample), at Day 0 and Month 1
Bicarbonate rate before dialysisDay 0, Month 1Mesure of bicarbonate rate before dialysis (Blood sample), at Day 0 and Month 1
Acid indol acetic dosage rateDay 0, Month 1 - Only for patient in dialysis in Assistance Publique Hopitaux de MarseilleBlood sample before dialysis at Day 0 and Month 1
Questionnaire The 5-level EQ-5D version (EQ-5D-5L)Day 0, Month 1Questionnaries Quality of life EQ-5D-5L for patients, at Day 0 and Month 1. Scale ranging from 0 to 100, higher scores mean a better outcome.
Questionnaire The Kidney Disease Quality of Life 36-item short form survey (KDQoL)Day 0, Month 1Questionnaries Quality of life for patients KDQoL, at Day 0 and Month 1. Scale ranging from 0 to 100, higher scores mean a better outcome.
Indoxyl sulfate dosing rateDay 0, Month 1 - Only for patient in dialysis in Assistance Publique Hopitaux de MarseilleBlood sample before dialysis at Day 0 and Month 1
Para cresyl sulfate dosage rateDay 0, Month 1 - Only for patient in dialysis in Assistance Publique Hopitaux de MarseilleBlood sample before dialysis at Day 0 and Month 1

Countries

France

Contacts

CONTACTRomain Vial, Dr
Romain.vial@ap-hm.fr0491383569

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026